INQOVI update
I was diagnosed and treated for AML in March 2024. The MRD blood tests have found no evidence of my FLT3 or NPM1 mutations and I am in deep remission from AML. I continued on “maintenance” with Dacogen and Venetaclax every 6-7 weeks. However my numbers seldom, if ever, get into or stay in the normal range. Especially true of my neutrophils. My BMB last December discovered the SF3B1 mutation indicating MDS …typically a precursor to AML. My team started me on INQOVI in June (it was approved in May). Convenient yes just 2 pills two days in a row every 42 days. After about 3 weeks I noticed I was losing my hair. The INQOVI side effects did not mention hair loss. Turns out that the clinical trial didn’t note it. The pharmacist confirmed with the Manufacturer hair loss was minimal in the trial but was a side effect. Losing my hair put me right back to when I was diagnosed/treated for AML. I requested and am now off INQOVI and back on Dacogen in the hopes my hair will stop falling out. I hope this update is helpful!
Interested in more discussions like this? Go to the Blood Cancers & Disorders Support Group.
Connect

Good morning, @sonieaml. Thanks for the update on your Inqovi experience. The hair loss side-effect is unfortunate. I’m just curious about your stopping the Inqovi and returning to Dacogen. Was the Dacogen as effective in controlling the newly discovered SF3B1 mutation?
Thanks @loribmt good question. My next BMB on 12/2 will provide an update. I haven’t had a BMB since the SF3B1 mutation was found last December. I will share when the results are in.
-
Like -
Helpful -
Hug
2 Reactions